Pharmaceutical Executive

Pharmaceutical Executive Issue Alert Having trouble viewing this email? Click here

Web Version | Share with a colleague | View Digital Edition | Subscribe

In our July issue of Pharmaceutical Executive
FEATURES

Cover Story
Compliance Disruptors
Lisa Henderson
Big pharma compliance leaders Bryant Aaron (Novartis) and Jennifer McGee (Otsuka) discuss the strategic move to principles-based policies at their companies and the impact of other emerging forces influencing industry compliance practice.
Download the digital issue

Compliance
Asia's Complex Landscape
Julian Upton
A look at some of the key pharma compliance challenges prevalent in the Asia-Pacific region.
Download the digital issue

Compliance
The 'Quality' Imperative
Brad Pedrow
How pharma companies can bolster their quality management programs to meet FDA's evolving compliance requirements.
Download the digital issue

Executive Q&A
Creating an 'Unbossed' Environment in the Workplace
Lisa Henderson
Daniel Manea, Novartis's US head of people and organization, talks about how the company's cultural transformation aims to strengthen and empower its talent base.
Download the digital issue

ALSO IN THIS ISSUE
European Pricing Talks: A lot of Smoke—or is it Fire?
Reflector
What to make of the simmering public and political angst …Read more

FDA Maps Pathway to More Accessible Biosimilars
Jill Wechsler
New guidances open the door to interchangeables and less costly insulin …Read more

Pricing in DTC: Adjusting to the New World
Jeremy Schafer
Strategies for pharma in delivering the full picture to patients …Read more

Top Trends, Takeaways from DIA
Lisa Henderson
Highlighting the biggest observations from this year's DIA Annual Meeting—topics likely to continue to dominate industry headlines for the foreseeable future …Read more

Download the
issue:

WEBCASTS

AI-powered Biomedical Literature Discovery supporting Science-based Business Decisions

Patient Adherence: A Hard Pill to Swallow?

Using Real-World Evidence for U.S. Regulatory Decision-Making: What Pharma Needs to Know

Japan Market Entry: How to Navigate the Clinical Development Regulatory Environment and Best Methods to Utilize Opportunities

Patient Assistance Centers of Excellence: The Next Generation of Brand Support

Bringing Intelligence to Drug Discovery—The Importance of Contextual Information at All Levels

Seizing Opportunities in Japan, the Second Largest Innovation-Driven Pharmaceutical Market

Pharmaceutical Executive is free to qualified subscribers. To subscribe, click here.

Click here to contact the Pharmaceutical Executive sales team.